Invitation to submit the abstract for CRRM2017 conference
The international conference
INNOVATIONS IN
CANCER RESEARCH AND REGENERATIVE MEDICINE 2017
Ho Chi Minh city, Vietnam
February 2, 2017
Dear Colleagues,
The 3rd CRRM, the international conference about Cancer Research and Regenerative Medicine co-organized by University of Science, VNU-HCM, Viet Nam; University of California, Los Angeles (UCLA), US; and MD Anderson Cancer Center, The University of Texas, US will be held at the University of Science, VNU-HCM, Ho Chi Minh on Sept 10-13, 2017. CRRM is an international forum for all scientists, researchers, doctors, students about cancer research and regenerative medicine. The conference consistently draws senior- and junior-level professionals from multiple sectors, providing a valuable combination of experience, enthusiasm, and varied perspectives to the discussions.
CRRM2017 is introduced by Nature (NatureEvent), International Society for Stem Cell Research (ISSCR), Asian Federation of Biotechnology (AFOB)…
All accepted abstracts will be published in Biomedical Research and Therapy (indexed by ESCI, Web of Science, EMBASE, DOAJ, EBSCO…); and fulltexts will be published in Advances in Experimental Medicine and Biology (indexed SCIE, Scopus, Pubmed, EMBASE… Impact Factor (Thomson Reuters) 1.953 in 2015/2016).
On behalf of organizing committee, I would like to invite you to submit abstracts/full-texts and participate this conference.
Your participation and assistance will be crucial to the success of this meeting. We eagerly look forward to your acceptance of this invitation and participation in this meeting by June 30, 2017. If you accept the invitation, please us your abstract as soon as possible.
Thank you very much.
With best regards
Phuc Van PHAM
Program Chair, CRRM2017
Email: pvphuc@hcmuns.edu.vn
![[CFP] Breast Cancer](https://static.wixstatic.com/media/f68a5a_14b1a4f93d0a438d87abbdf64a90f34b~mv2.png/v1/fill/w_392,h_179,fp_0.50_0.50,lg_1,q_95,enc_auto/f68a5a_14b1a4f93d0a438d87abbdf64a90f34b~mv2.png)
![[CFP]: Special Issue on
Safety of Stem Cell Transplantation](https://static.wixstatic.com/media/f68a5a_164eab5d82f0443db19d0fd06b76828b~mv2.png/v1/fill/w_1024,h_574,fp_0.50_0.50,q_95,enc_auto/f68a5a_164eab5d82f0443db19d0fd06b76828b~mv2.png)
![[CFP] Breast Cancer](https://static.wixstatic.com/media/f68a5a_14b1a4f93d0a438d87abbdf64a90f34b~mv2.png/v1/fill/w_212,h_120,fp_0.50_0.50,q_95,enc_auto/f68a5a_14b1a4f93d0a438d87abbdf64a90f34b~mv2.png)
![[CFP]: Special Issue on
Safety of Stem Cell Transplantation](https://static.wixstatic.com/media/f68a5a_164eab5d82f0443db19d0fd06b76828b~mv2.png/v1/fill/w_212,h_212,fp_0.50_0.50,q_95,enc_auto/f68a5a_164eab5d82f0443db19d0fd06b76828b~mv2.png)